Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

9

Number of overlapping holdings

39.1%

% of XDNA's 23 holdings also in IDNA

21.4%

% of IDNA's 46 holdings also in XDNA

Overlap by Weight
Sector Drift (XDNA minus IDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XDNA
Weight
in IDNA
Overlap
CRISPR THERAPEUTICS AG 15.1% 4.6% 4.6%
BEAM THERAPEUTICS, INC. 13.7% 4.2% 4.2%
SANOFI-AVENTIS 3.2% 4.4% 3.2%
EDITAS MEDICINE, INC. 5.7% 2.3% 2.3%
INTELLIA THERAPEUTICS, INC. 8.7% 2.2% 2.2%

Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to IDNA
CRISPR THERAPEUTICS AG 10.5%
THERMO FISHER SCIENTIFIC INC 9.5%
BEAM THERAPEUTICS, INC. 9.5%
INTELLIA THERAPEUTICS, INC. 6.5%
PRIME MEDICINE, INC. 5.7%
VERVE THERAPEUTICS, INC. 4.5%
POSEIDA THERAPEUTICS, INC. 4.1%
ABBVIE INC 3.8%
CARIBOU BIOSCIENCES, INC. 3.7%
EDITAS MEDICINE, INC. 3.4%
XDNA Underweight Relative to IDNA
BLUEPRINT MEDICINES CORP. -5.6%
EXELIXIS INC -5.4%
BIONTECH SE SPONSORED ADR -4.4%
TAKEDA PHARMACEUTICAL CO LTD -4.2%
TWIST BIOSCIENCE CORP. -4.1%
GINKGO BIOWORKS HOLDINGS INC CLASS A -4.1%
ROCHE HOLDING LTD -4.0%
REGENERON PHARMACEUTICALS -3.9%
BEIGENE, LTD. -3.9%
GENMAB A/S -3.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY